LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads) on and off LinkedIn. Learn more in our Cookie Policy.
Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings.
Seasoned Software Sales Executive | 20+ Years of Empowering Enterprises with Cutting-Edge Solutions | Spearheading Innovation & Security at Check Point
https://lnkd.in/desKrhxG
* Obstetric Vasculopathies: Where are we? Where are we going?
* Sharing a journey of original research and clinical effects in OVs including
Preeclampsia of thirty years
* How and why is early onset preeclampsia bad?
* Why and How is colour Doppler so efficient in predicting preeclampsia and
other OVs
* What is the latest in prevention and treatment of Preeclampsia and other
OVs
Completely change your practice of these conditions by watching this video with latest concepts
EACTAIC seminar!
LV unloding in tha heart failure setting
Join us to heart what's new!
The most relevant personalities about heart failure TOPIC from Policlinico Sant'Orsola Malpighi in Bologna, and the partecipation of Professor Fabio Guarracinohttps://lnkd.in/dBvWZyUv
Want to learn the fundamentals of identifying pneumonia in kids? This video teaches how to identify and treat pneumonia in infants and children. Chapters in this video cover the pathophysiology, clinical presentation, diagnosis, management, and complication that arise in the treatment of pneumonia. https://lnkd.in/e-unCKTW
Want to learn the fundamentals of identifying pneumonia in kids? This video teaches how to identify and treat pneumonia in infants and children. Chapters in this video cover the pathophysiology, clinical presentation, diagnosis, management, and complication that arise in the treatment of pneumonia. https://lnkd.in/e-unCKTW
President @ Cameron Dermatology | CEO @ Equity Medical | Assistant Clinical Professor @ Mount Sinai
Dermatologist | Clinical Trialist | Educator | Founder
My main takeaways from another amazing Dermsquared#FallClinical:
1) The dermatology pipeline is immense.
Numerous novels MoAs are incoming for #HidradenitisSuppurativa#AtopicDermatitis and #ChronicSpontaneousUrticaria. While big Pharma including most notably SanofiEli Lilly and CompanyAbbVieIncyteJohnson & JohnsonNovartis and Takeda have many Ph2-Ph3 assets, a plethora of smaller biotech interests including, but certainly not limited, to AlumisApogee TherapeuticsOruka TherapeuticsQ32 Bio Inc.Celldex TherapeuticsMoonLake Immunotherapeutics (NASDAQ: MLTX)AnaptysBio are also involved.
2) "The Year of the JAK"
Since it may be a while until many of the these assets can make it to the finish line, we need to utilize what we have available right now for our patients (which is still pretty good!). I heard Dr. Theodore Rosen call this the "The Year of the JAK" and I couldn't agree more. Janus kinase inhibitors are being used more and more as dermatology providers come to the realization that these therapies can be used with a high degree of safety with proper patient selection and counseling. As these therapies get approved for more conditions of unmet need (i.e. Rinvoq in #vitiligo and #alopeciaareata, povorcitinib in #HS), our patients will expect us to be competent in prescribing these oral small molecules.
3) We are so blessed to be in dermatology.
Not just dermatologists, but all of us including our industry colleagues, advanced practice providers, biologics coordinators, medical assistants, front office staff, and everyone else... our patients for the most part are doing well and on good therapies, and I've developed so many friendships across the dermatology ecosystem for which I'm very grateful.
🎥 #SCAI2024 Program Chair J. Dawn Abbott, MD, FSCAI, highlights the top moments from this year’s conference, while #SCAI2025 Program Chair Binita Shah, MD, FSCAI, shares exciting reasons to attend next year! Watch the interview and share your favorite moments from this year and your hopes for 2025 in the comments below! ➡️ https://lnkd.in/guSXGhSt#InterventionalCardiology
Join hosts Jon and Biddy as they welcome special guest Dr. William Cirocco. Dr. Cirocco sheds light on pivotal moments in the 125-year history of ASCRS, offering insights into his journey into medicine, his notable research, and his contribution to the Historical Perspectives segments in the DC&R Journal. The discussion explores lessons from the past that can shape the future trajectory of ASCRS and our mission. Listen now: https://lnkd.in/etNTTvZ6
Vice President of Finance
5moCongratulations to Dr. Heidi!! Great job! I’m so proud of her!